Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single...

por Kong, Danqing, Ping, Nana, Gao, Xin, Zou, Rui, Wang, Peng, Wu, Depei, Jin, Zhengming, Qu, Changju
Publicado 2023

Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion

por Ping, Nana, Qiu, Huiying, Wang, Qian, Dai, Haiping, Ruan, Changgeng, Ehrentraut, Stefan, Drexler, Hans G., MacLeod, Roderick A. F., Chen, Suning
Publicado 2015

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients

por Qu, Changju, Zou, Rui, Wang, Peng, Zhu, Qian, Kang, Liqing, Ping, Nana, Xia, Fan, Liu, Hailing, Kong, Danqing, Yu, Lei, Wu, Depei, Jin, Zhengming
Publicado 2022

Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature

por Li, Xuewei, Ping, Nana, Wang, Yong, Xu, Xiaoyu, Gao, Lijuan, Zeng, Zhao, Zhang, Ling, Zhang, Zhibo, Xie, Yiyu, Ruan, Changgeng, Wu, Depei, Jin, Zhengming, Chen, Suning
Publicado 2021

Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma

por Ping, Nana, Qu, Changju, Li, Mengyun, Kang, Liqing, Kong, Danqin, Chen, Xiaochen, Wu, Qian, Xia, Fan, Yu, Lei, Yao, Hong, Yan, Lingzhi, Wu, Depei, Jin, Zhengming
Publicado 2022

Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22)

por Yao, Hong, Pan, Jinlan, Wu, Chunxiao, Shen, Hongjie, Xie, Jundan, Wang, Qinrong, Wen, Lijun, Wang, Qian, Ma, Liang, Wu, Lili, Ping, Nana, Zhao, Yun, Sun, Aining, Chen, Suning
Publicado 2015